GlassScriptPhysician profile
Nina Rashedi
NPI 1215252705
$3,191.75
in general payments reported to CMS, 2019-2025
6 companies · $3,128 in 2025
The $3,128 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.70 · 2025: $3,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,404 · Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,403.52 |
| Food and Beverage | $724.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,897.69 | 2025 | Triclip |
| Siemens Medical Solutions USA, INC. | $176.72 | 2025 | Somatom Go.Top |
| Janssen Pharmaceuticals, INC | $35.61 | 2019 | |
| Bridgebio Pharma, INC. | $30.41 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $28.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.23 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Rashedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.